Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease

Autor: Emilie (E.) van Lingen, Simon (S. M. D.) Baunwall, Simone (S. C.) Lieberknecht, Nicolas (N.) Benech, Gianluca (G.) Ianiro, Harry (H.) Sokol, Alessandro (A.) Gasbarrini, Giovanni (G.) Cammarota, Marcel (M. K.) Eriksen, Andrea (A. E.) van der Meulen-de Jong, Elizabeth (E. M.) Terveer, Hein (H. W.) Verspaget, Maria (M.) Vehreschild, Christian (C. L.) Hvas, Josbert (J. J.) Keller

Publikováno v: van Lingen, E, Baunwall, S, Lieberknecht, S, Benech, N, Ianiro, G, Sokol, H, Gasbarrini, A, Cammarota, G, Eriksen, M, van der Meulen-de Jong, A, Terveer, E, Verspaget, H, Vehreschild, M, Hvas, C & Keller, J 2023, ' Short-and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease ', Therapeutic Advances in Gastroenterology, vol. 16 . https://doi.org/10.1177/17562848231156285

Background: Patients with inflammatory bowel disease (IBD) are at an increased risk of developing Clostridioides difficile infection (CDI). Treatment of CDI in patients with IBD is challenging due to higher failure rates and concomitant IBD activity.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae34fbbe36826e125dd2de3ffee8d38
https://doi.org/10.1177/17562848231156285